| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2006.05.011 |
| P698 | PubMed publication ID | 16876902 |
| P2093 | author name string | Michael A Heneghan | |
| Andrew J Muir | |||
| David A Tendler | |||
| Jeffrey D Bornstein | |||
| Michael L Allan | |||
| P433 | issue | 4 | |
| P921 | main subject | azathioprine | Q18939 |
| autoimmune hepatitis | Q786844 | ||
| P304 | page(s) | 584-591 | |
| P577 | publication date | 2006-06-23 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis | |
| P478 | volume | 45 |
| Q28551326 | Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis |
| Q35906055 | Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease |
| Q59349440 | Autoimmune hepatitis |
| Q86886381 | Autoimmune hepatitis |
| Q86954391 | Autoimmune hepatitis |
| Q60932817 | Autoimmune hepatitis: Appraisal of current treatment guidelines |
| Q42358509 | Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments |
| Q34522550 | Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people |
| Q22305507 | Clinical features and management of autoimmune hepatitis |
| Q37106402 | Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly |
| Q50513527 | Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis. |
| Q38609184 | Current concepts in the diagnosis and management of autoimmune hepatitis |
| Q34615157 | Current therapy for autoimmune hepatitis |
| Q28076505 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions |
| Q92166689 | Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases |
| Q37969669 | Diagnosis and treatment of autoimmune hepatitis |
| Q33688293 | Difficult treatment decisions in autoimmune hepatitis |
| Q58803023 | Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study |
| Q60926015 | Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis |
| Q64063498 | Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis |
| Q33733501 | Screening for 392 polymorphisms in 141 pharmacogenes |
| Q37738804 | The use of immunosuppression in autoimmune hepatitis: A current literature review |
| Q34149523 | Treatment of autoimmune hepatitis: A review of current and evolving therapies |
| Q43457961 | Use of a xanthine oxidase inhibitor in autoimmune hepatitis. |
Search more.